Skip to content
OpenCapital
Get started

Achieve Life Sciences ACHV Enterprise value

Enterprise value at other companies

Pfizer logo
PfizerPFE
$222.4B+9.2%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$1.75B—
Philip Morris International logo
Philip Morris InternationalPM
$304.25B+4.1%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation

See full
Market cap$585.16M+404%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Calculated from Achieve Life Sciences’s reported figures.

$156.5Mmarket cap+$5.6Mtotal debt−$28.1Mcash and equivalents=$134.08M

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's enterprise value?
Achieve Life Sciences (ACHV) reported enterprise value of $134.08M in Q1 2026.
How has Achieve Life Sciences's enterprise value changed year-over-year?
Achieve Life Sciences's enterprise value increased by 65.7% year-over-year, from $80.9M to $134.08M.
What is the long-term trend for Achieve Life Sciences's enterprise value?
Over 5 years (2020 to 2025), Achieve Life Sciences's enterprise value has grown at a 43.3% compound annual growth rate (CAGR), from $40.89M to $247.41M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.